Literature DB >> 16843262

Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature.

Saori Furuta1, Ju-Ming Wang, Shuanzeng Wei, Yung-Ming Jeng, Xianzhi Jiang, Bingnan Gu, Phang-Lang Chen, Eva Y-H P Lee, Wen-Hwa Lee.   

Abstract

BRCA1 exerts transcriptional repression through interaction with CtIP in the C-terminal BRCT domain and ZBRK1 in the central domain. A dozen genes, including angiopoietin-1 (ANG1), a secreted angiogenic factor, are corepressed by BRCA1 and CtIP based on microarray analysis of mammary epithelial cells in 3D culture. BRCA1, CtIP, and ZBRK1 form a complex that coordinately represses ANG1 expression via a ZBRK1 recognition site in the ANG1 promoter. Impairment of this complex upregulates ANG1, which stabilizes endothelial cells that form a capillary-like network structure. Consistently, Brca1-deficient mouse mammary tumors exhibit accelerated growth, pronounced vascularization, and overexpressed ANG1. These results suggest that, besides its role in maintaining genomic stability, BRCA1 directly regulates the expression of angiogenic factors to modulate the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843262     DOI: 10.1016/j.ccr.2006.05.022

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

1.  IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells.

Authors:  Saori Furuta; Yung-Ming Jeng; Longen Zhou; Lan Huang; Irene Kuhn; Mina J Bissell; Wen-Hwa Lee
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

3.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

4.  Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.

Authors:  Kazi Mokim Ahmed; Connie Y Tsai; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

5.  C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter.

Authors:  D L Madison; J R Lundblad
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

Review 6.  Crosstalk between the DNA damage response, histone modifications and neovascularisation.

Authors:  Athanassios Vassilopoulos; Chu-Xia Deng; Triantafyllos Chavakis
Journal:  Int J Biochem Cell Biol       Date:  2009-11-27       Impact factor: 5.085

Review 7.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

Review 8.  BRCA1, hormone, and tissue-specific tumor suppression.

Authors:  Yanfen Hu
Journal:  Int J Biol Sci       Date:  2008-12-13       Impact factor: 6.580

9.  Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation.

Authors:  Bingnan Gu; Peng Sun; Yuanyang Yuan; Ricardo C Moraes; Aihua Li; Andy Teng; Anshu Agrawal; Catherine Rhéaume; Virginia Bilanchone; Jacqueline M Veltmaat; Ken-Ichi Takemaru; Sarah Millar; Eva Y-H P Lee; Michael T Lewis; Boan Li; Xing Dai
Journal:  J Cell Biol       Date:  2009-06-01       Impact factor: 10.539

10.  Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.

Authors:  Núria Bonifaci; Antoni Berenguer; Javier Díez; Oscar Reina; Ignacio Medina; Joaquín Dopazo; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Med Genomics       Date:  2008-12-18       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.